These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23207166)

  • 21. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
    Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two medical abortion regimens for late first-trimester termination of pregnancy: a prospective randomized trial.
    Dalenda C; Ines N; Fathia B; Malika A; Bechir Z; Ezzeddine S; Hela C; Badis CM
    Contraception; 2010 Apr; 81(4):323-7. PubMed ID: 20227549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is misoprostol teratogenic? Misoprostol use during early pregnancy and its association with Möbius' syndrome.
    Pottie K
    Can Fam Physician; 1999 Feb; 45():315-6. PubMed ID: 10065304
    [No Abstract]   [Full Text] [Related]  

  • 24. Effectiveness of 400 or 600 micrograms of vaginal misoprostol for terminations of early pregnancies.
    Ruangchainikhom W; Phongphissanou E; Bhekasuta J; Sarapak S
    J Med Assoc Thai; 2006 Jul; 89(7):928-33. PubMed ID: 16881422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of a single misoprostol regimen in the first and second trimester termination of pregnancy.
    van Bogaert LJ; Sedibe TM
    J Obstet Gynaecol; 2007 Jul; 27(5):510-2. PubMed ID: 17701803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thalidomide and misoprostol: Ophthalmologic manifestations and associations both expected and unexpected.
    Miller MT; Ventura L; Strömland K
    Birth Defects Res A Clin Mol Teratol; 2009 Aug; 85(8):667-76. PubMed ID: 19639653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective double-blinded, randomized, placebo-controlled trial on the use of letrozole pretreatment with misoprostol for second-trimester medical abortion.
    Lee VC; Tang OS; Ng EH; Yeung WS; Ho PC
    Contraception; 2011 Dec; 84(6):628-33. PubMed ID: 22078193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of oral versus vaginal misoprostol on cervical dilatation in first-trimester abortion: a double-blind, randomized study.
    Inal MM; Ertopçu K; Arici A; Ozelmas I
    Eur J Contracept Reprod Health Care; 2003 Dec; 8(4):197-202. PubMed ID: 15006266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First-trimester pregnancy termination with 800 microg of vaginal misoprostol every 12 h.
    Salakos N; Kountouris A; Botsis D; Rizos D; Gregoriou O; Detsis G; Creatsas G
    Eur J Contracept Reprod Health Care; 2005 Dec; 10(4):249-54. PubMed ID: 16448952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregnancy outcome after in utero exposure to colchicine.
    Diav-Citrin O; Shechtman S; Schwartz V; Avgil-Tsadok M; Finkel-Pekarsky V; Wajnberg R; Arnon J; Berkovitch M; Ornoy A
    Am J Obstet Gynecol; 2010 Aug; 203(2):144.e1-6. PubMed ID: 20579964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
    Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
    Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study on sublingual versus oral and vaginal administration of misoprostol for late first and early second trimester abortion.
    Ganguly RP; Saha SP; Mukhopadhyay S; Bhattacharjee N; Bhattacharyya SK; Patra KK
    J Indian Med Assoc; 2010 May; 108(5):283-4, 286. PubMed ID: 21121402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical abortion at first trimester of pregnancy with misoprostol.
    Ayati S; Roudsari FV; Khadem N; Shakeri MT
    Saudi Med J; 2008 Dec; 29(12):1739-42. PubMed ID: 19082224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transvaginal ultrasound measurement of cervical length and efficacy of misoprostol in first-trimester pregnancy failure.
    Agostini A; Capelle M; Ronda I; Bretelle F; Cravello L; Blanc B
    Ultrasound Obstet Gynecol; 2007 Jun; 29(6):671-3. PubMed ID: 17427895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
    Tang OS; Lau WN; Chan CC; Ho PC
    BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate. A single agent for early abortion.
    Schaff EA; Penmetsa U; Eisinger SH; Franks P
    J Reprod Med; 1997 Jan; 42(1):56-60. PubMed ID: 9018647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-trimester exposure to alprazolam.
    St Clair SM; Schirmer RG
    Obstet Gynecol; 1992 Nov; 80(5):843-6. PubMed ID: 1407925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion.
    Dahiya K; Mann S; Nanda S
    Arch Gynecol Obstet; 2011 Jul; 284(1):59-63. PubMed ID: 20652288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation.
    Murthy AS; Creinin MD; Harwood B; Schreiber C
    Contraception; 2005 May; 71(5):333-6. PubMed ID: 15854632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of embryotoxicity of misoprostol using the whole embryo culture assay].
    Campos E C; Cavieres MF
    Rev Med Chil; 2011 May; 139(5):613-7. PubMed ID: 22051712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.